First Wave Bio Investors Sue In Del. For AzurRx Merger Money

By Leslie A. Pappas (May 20, 2022, 6:00 PM EDT) -- Former shareholders of biopharmaceutical company First Wave Bio Inc., which merged with AzurRx BioPharma Inc. in 2021, sued the company in Delaware Chancery Court on Thursday, saying it had refused to make scheduled merger payments or make reasonable efforts to develop the products it promised....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!